Abbott Says Sandoz Marketed Generic Nimbex Too Soon

Law360, New York (August 29, 2012, 2:19 PM EDT) -- An Abbott Laboratories unit sued Sandoz Inc. for $25 million in Illinois on Tuesday, claiming the rival drugmaker breached a settlement agreement reached during prior litigation by prematurely offering to sell a generic version of skeletal muscle relaxant Nimbex.

In a suit filed in Illinois federal court, AbbVie Inc. — which Abbott is scheduled to spin off as a stand-alone research-based pharmaceutical business later this year — accuses Sandoz of violating a June 2010 settlement agreement that resolved litigation over Sandoz’s bid to produce and sell...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.